Mexico approves prostate cancer treatment recently developed in Israel

Mexico’s COFEPRIS health authority has authorized the use of an early-stage prostate cancer drug and laser therapy developed by the Weizmann Institute of Science in Rehovot, (about 20 kilometers (12 miles) south of Tel Aviv) in collaboration with Luxembourg’s Steba Biotech.

http://www.theyucatantimes.com/2016/01/mexico-approves-prostate-cancer-treatment-recently-developed-in-israel/

Photo: Weizmann Institute of Science (Photo: Michael Jacobson / Wikimedia Commons)